Latest News & Features
Refine search
MedTech
The Finnish wearable tech company strikes again after the Indian rival’s redesigned ring cleared US Customs, with one of Oura’s asserted patents issued just two days earlier. 29 October 2026
Careers
The 95-year-old Wall Street law firm’s management committee has recommended an “orderly wind-down” following a wave of partner exits this year, despite a significant expansion of the IP practice in 2025. 29 October 2026
MedTech
Despite earlier wins at the UPC and EPO, a key heart valve patent has been revoked on appeal, with the latest ruling highlighting diverging approaches to patent validity in Europe and raising questions ahead of a separate UPC appeal. 29 October 2026
Careers
The US firm has added a top litigator with experience in pharmaceutical disputes, AI and technology, and complex cross-border litigation, who also made history as the youngest person appointed deputy master of the High Court’s Business and Property Division. 29 October 2026
Biotech
Both companies have agreed to dismiss claims and counterclaims involving Amgen’s 2 mg aflibercept biosimilar, while their wider feud continues. 28 October 2026
MedTech
The 179-page lawsuit alleges that a Boston-based company used patented technology and confidential information from former employees to develop a competing cardiac imaging product. 27 October 2026
Careers
The departing partners bring expertise across molecular biology, biochemistry, small molecule and peptide drugs, including blockbuster therapies, as well as chemical and mechanical technologies. 27 October 2026
In-house counsel
Umicore’s Sean Alexander has seen the profession change considerably over three decades, but some of its biggest changes may still lie ahead. He tells LSIPR why AI is prompting difficult decisions, what he is no longer willing to pay external counsel for and why Europe is the place to watch. 26 October 2026
Careers
After introducing Microsoft Copilot and specialist legal AI platforms Solve Intelligence and Legora, the firm says the chief technology officer’s priorities will include expanding the use of AI in patent and legal work. 26 October 2026
Biotech
Following the Federal Circuit’s decision to uphold the invalidation of three patents, the parties are set to drop their remaining claims, despite 10x’s separate multi-million dollar jury win. 23 October 2026


